ProMIS Neurosciences
Toronto
About ProMIS Neurosciences
ProMIS Neurosciences is a development-stage biotech company that discovers and develops precision therapeutics and companion diagnostics for early detection and effective treatment of neurodegenerative diseases, in particular, Alzheimer’s disease (AD) and amyotrophic lateral sclerosis (ALS). It was founded in 2004 and headquartered in Toronto, Canada.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Estimated revenue: $10K – $50K
- Total funding: $151.5M
- Funding stage: IPO
- Last round: Post-IPO Equity (Jan 2026)
- Ticker: nasdaq:PMN
- Website: promisneurosciences.com
- Phone: (416) 847-6898
Industries & Categories
Biotechnology, Health Diagnostics, Medical, Neuroscience, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/promis-neurosciences-102353 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.